Lerming Pharma
Latest round
- Series B
Last raised
- Jun 2024
Total raised
- $14M
Investors
- 6
About Lerming Pharma
Established in 2019 and based in Suzhou, China, Lerming Pharma is a pharmacy company that focuses on the research and development, production and sales of innovative pharmaceutical preparations. The company headquarters is located in Suzhou, with a research and development center in Beijing, and business development departments in the United States and Japan which are responsible for the introduction of overseas projects. It has a factory building of 15000 square meters. The company engaged in the research and development and production of preparations in the transdermal field. It corporates with many North American biopharmaceutical companies and introduces preparation platforms. The company provides transdermal preparation products including gel patches, hot melt adhesives, and solvent adhesives. The company’s revenue is generated by providing medicines.
Who invested in Lerming Pharma
6 investors across 2 rounds
See all investors in Lerming Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Lerming Pharma
Who invested in Lerming Pharma?
Lerming Pharma has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Lerming Pharma raised?
Lerming Pharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Lerming Pharma last raise money?
Lerming Pharma's most recent round on record is a Series B, in Jun 2024.
What does Lerming Pharma do?
Established in 2019 and based in Suzhou, China, Lerming Pharma is a pharmacy company that focuses on the research and development, production and sales of innovative pharmaceutical preparations.
Where is Lerming Pharma headquartered?
Lerming Pharma is headquartered in Suzhou, China.
Which VCs invest in companies like Lerming Pharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Lerming Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Lerming Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.